首页 > 市场调查报告书 > 医疗设备

整形外科

市场调查报告书

商品编码

1935212

按产品类型、应用和地区分類的骨移植和骨替代材料市场

Bone Graft and Substitutes Market, By Product Type, By Application, By Geography

出版日期: 2026年01月21日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，骨移植和骨替代材料市场价值将达到 44 亿美元，预计到 2033 年将达到 66 亿美元，2026 年至 2033 年的复合年增长率为 6.9%。

报告覆盖范围		报告详情
基准年：	2025	2026年市场规模：	44亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	6.90%	2033 年的预测值：	66亿美元

骨移植整合是指供体骨组织与受体体内新沉积骨组织之间的相互嵌合与包裹过程。它是一种用途广泛的技术，利用自然机制取代缺失的骨组织并促进骨骼生长。自体骨移植是最成功的骨移植方法，被认为是骨替代的黄金标准。骨移植用途广泛，包括填充囊肿或肿瘤造成的空腔，以及促进初次治疗后未癒合的骨折癒合。

市场动态

根据《材料科学与医学材料杂誌》（2014）的报告，骨移植是继输血之后全球第二常用的组织移植技术。该杂誌2014年的统计数据显示，每年进行超过200万例骨移植手术，光在美国就进行了超过50万例骨移植植入手术。这主要归功于新型器械的易用性和操作性、更高的安全性、更短的手术时间、更低的术中成本以及对各种临床挑战的适应性。

全球骨移植和骨替代材料市场预计在预测期内将显着成长，因为製造商正采用新技术开发创新移植骨替代物。这包括推出新型生长因子增强型移植材料，以提高术后恢復的移植品质。例如，2015年，私人公司Therapedics, Inc.的胜肽增强型移植材料「i-Factor」获得美国FDA核准，用于颈切除术和融合手术。此移植材料基于小分子胜肽（P-15）技术，可透过细胞黏附和活化来促进骨骼生长。

本次调查的主要特点

本报告以 2018 年为基准年，对 2019 年至 2027 年的全球骨移植和骨替代市场进行了详细分析。
我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、新技术发布或核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
本报告根据以下参数对全球骨移植和骨替代市场的主要企业进行了分析：公司概况、财务表现、技术组合、地理分布、分销策略、关键发展和策略。
本报告的研究结果将使企业负责人和经营团队能够就未来的技术投资、政府政策、技术升级、市场扩张和行销策略做出明智的决策。
这份全球骨移植和骨替代市场报告将为该市场中的各种相关人员提供有价值的信息，包括投资者、技术製造商、经销商、供应商、研究和咨询公司、新参与企业和金融分析师。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第七章竞争情势

热图分析
市占率分析（3x3矩阵）
公司简介
- Ace Surgical Supply Co., Inc.
- Exactech, Inc.
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation
- BioHorizons Implant Systems, Inc.
- Globus Medical, Inc.
- RTI Surgical, Inc.
- Geistlich Pharma
- Megagen
- Novadip Biosciences
- Mesoblast Ltd.
- Alphatec Spine, Inc.
- Institut Straumann AG
- NuVasive, Inc.
- OsteoMed LLC
- KYERON Medical Innovations
- ORTHOFIX INTERNATIONAL NV
- Johnson &Johnson
- Bone Therapeutics SA
- K2M Group Holdings, Inc.
- OsteoNovus

第八章分析师建议

机会
分析师观点
Coherent Opportunity Map

第九章各节

参考
调查方法

简介目录

Product Code: CMI1050

Bone Graft And Substitutes Market is estimated to be valued at USD 4.40 Bn in 2026 and is expected to reach USD 6.6 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.90%	2033 Value Projection:	USD 6.6 Bn

The incorporation of a bone graft can be defined as a procedure of interdigitation and envelopment of the donor bone tissue with the new bone deposited by the recipient. It is a versatile that replaces the lost bone tissue, enhances bone growth using natural mechanisms. The natural bone graft are the most successful types of bone grafts and are considered to be the gold standard for replacement of missing bones. Bone grafts are in used in various purposes such as to fill the cavities resulting from cysts, tumors, or other causes, to stimulate the healing of fractures that have failed to heal after an initial treatment attempt, and others.

Market Dynamics

According to the Journal of Materials Science and Materials in Medicine, 2014, bone grafting frequency is the second most frequent tissue transplantation technique carried out globally after blood transfusion. The 2014 statistics reported in the Journal of Materials Science and Materials in Medicine, states that over 2 million bone grafting procedures are performed annually with over 500,000 graft implant procedures carried out in the U.S. itself. This is attributed to the ease of use and handling of new devices, improved safety profile, time advantages, intraoperative costs as well as the adaptability to a variety of clinical challenges.

The global bone graft, substitutes and membrane market is expected to witness a significant growth over the forecast period, owing to adoption of new technologies by manufacturers for development of innovative and novel bone graft substitutes. This includes the launches of novel growth factor enhanced grafts that improves the quality of grafts in terms of post-surgical recovery. For instance, in 2015, Cerapedics, a privately owned orthobiologics company received the U.S. FDA approval for i-Factor, which is a peptide enhanced graft that is used in cervical discectomy and fusion. The graft was based on small peptide (P-15) technology that helps in supporting bone growth through cell attachment and activation

Key features of the study

This report provides in-depth analysis of the global bone graft and substitutes market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019-2027), considering 2018 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new technology launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global bone graft and substitutes market based on the following parameters - company overview, financial performance, technology portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Ace Surgical Supply Co., Inc., NovaBone Product, LLC., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation., BioHorizons Implant Systems, Inc., Globus Medical, Inc., RTI Surgical, Inc., Geistlich Pharma, Megagen, Novadip Biosciences, Mesoblast Ltd., Alphatec Spine, Inc., Institut Straumann AG, NuVasive, Inc., OsteoMed LLC, KYERON Medical Innovations, ORTHOFIX INTERNATIONAL N.V., Johnson & Johnson, Bone Therapeutics SA, K2M Group Holdings, Inc., and OsteoNovus
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to future technology launches, government initiatives, technological upgradation, market expansion, and marketing tactics
The global bone graft and substitutes market report caters to various stakeholders in this market, including investors, technology manufacturers, distributors, and suppliers for global bone graft and substitutes market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

By Product Type
- Bone Grafts
- Allografts
- Xenografts
- Bone Graft Substitutes
- Ceramics
- Composites
- Polymers
- Demineralized Bone Matrix
- Bone Morphogenetic Proteins
- Others
By Application
- Spinal Fusion
- Dental Bone Grafts
- Craniomaxillofacial
- Joint Reconstruction
- Trauma & Extremities
- Oncology
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Ace Surgical Supply Co., Inc.
- NovaBone Product, LLC.
- Exactech, Inc.
- Medtronic Plc.
- LifeNet Health
- Zimmer Biomet Holdings, Inc.
- Stryker Corporation.
- BioHorizons Implant Systems, Inc.
- Globus Medical, Inc.
- RTI Surgical, Inc.
- Geistlich Pharma
- Megagen
- Novadip Biosciences
- Mesoblast Ltd.
- Alphatec Spine, Inc.
- Institut Straumann AG
- NuVasive, Inc.
- OsteoMed LLC
- KYERON Medical Innovations
- ORTHOFIX INTERNATIONAL N.V.
- Johnson & Johnson
- Bone Therapeutics SA
- K2M Group Holdings, Inc.
- OsteoNovus

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Bone Graft And Substitutes Market, By Product Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Grafts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Allografts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Xenografts
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Graft Substitutes
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Ceramics
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Composites
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Polymers
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Demineralized Bone Matrix
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Bone Morphogenetic Proteins
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Others
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Bone Graft And Substitutes Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Spinal Fusion
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Dental Bone Graft
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Craniomaxillofacial
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Joint Reconstruction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Trauma & Extremities
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Bone Graft And Substitutes Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By Product Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- Ace Surgical Supply Co., Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
  - NovaBone Product, LLC.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Exactech, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
  - Medtronic Plc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- LifeNet Health
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Zimmer Biomet Holdings, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Stryker Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- BioHorizons Implant Systems, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Globus Medical, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- RTI Surgical, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Geistlich Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Megagen
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novadip Biosciences
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Mesoblast Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Alphatec Spine, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Institut Straumann AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- NuVasive, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- OsteoMed LLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- KYERON Medical Innovations
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- ORTHOFIX INTERNATIONAL N.V.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bone Therapeutics SA
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- K2M Group Holdings, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- OsteoNovus
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

8. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

按产品类型、应用和地区分類的骨移植和骨替代材料市场

Bone Graft and Substitutes Market, By Product Type, By Application, By Geography

市场动态